Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Amgen's Kyprolis and Blincyto on track for European approval

Amgen's Kyprolis and Blincyto on track for European approval Kyprolis (carfilzomib) was recommended for use in combination with Celgene's Revlimid (lenalidomide) and dexamethasone for patients with multiple myeloma who have received at least one prior therapy.

Amgen granted priority review for extended use of Kyprolis

Amgen granted priority review for extended use of Kyprolis If given the green light, the decision would represent the second FDA approval in six months for Kyprolis which was recently approved alongside Celgene's Revlimid (lenalidomide) and dexamethasone.

Cancer Drugs Fund axes 16 treatments after overspending

Cancer Drugs Fund axes 16 treatments after overspending Celgene's Imnovid (pomalidomide) and Revlimid (lenalidomide), for which the CDF received 1, 068 and 498 funding requests respectively April 2013 and March 2015 are also among those to be ... Wim Souverjins, general manager at Celgene UK &Ireland, said:

BMS' myeloma treatment accepted for priority review

BMS' myeloma treatment accepted for priority review The results showed that adding elotuzumab to treatment with Celgene's Revlimid (lenalidomide) and dexamethasone cut the risk of the disease progressing by 30% and additionally extended remission by over four

Myeloma market set to be $9bn by 2021

Myeloma market set to be $9bn by 2021 Additionally, approvals during the forecast period for drugs that will supplement the current market leader - Celgene's $4.9bn a year Revlimid (lenalidomide) - and offer improved therapeutic options, mainly in the

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics